| New Drug for Kidney Disease in Diabetes - RedOrbit |
|
|
RedOrbit Diabetes has become the most common single cause of end-stage renal disease (ESRD) in the US and Europe due to the facts that 1) diabetes, particularly type 2, is increasing in prevalence; 2) diabetes patients now live longer; and 3) patients with |